Deutsche Bank Initiates Coverage On Tandem Diabetes Care with Hold Rating, Announces Price Target of $15.5
Benzinga Newsdesk 4 months ago
Analyst RatingsNewsInitiationPrice Target
Deutsche Bank analyst Kieran Ryan initiates coverage on Tandem Diabetes Care (NASDAQ:TNDM) with a Hold rating and announces Price Target of $15.5.
Deutsche Bank analyst Kieran Ryan initiates coverage on Tandem Diabetes Care (NASDAQ:TNDM) with a Hold rating and announces Price Target of $15.5.